查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1822440

2032 年兒科神經系統器材市場預測：按產品、疾病狀況、服務/療法、最終用戶和地區分類的全球分析

Paediatric Neurology Device Market Forecasts to 2032 - Global Analysis By Product, Condition, Service & Treatment, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球兒科神經設備市場預計在 2025 年達到 43 億美元，到 2032 年將達到 79 億美元，預測期內的複合年成長率為 8.9%。

兒科神經系統設備是專門用於診斷、監測和治療從新生兒到青少年兒童神經病變的醫療設備或技術。這些醫療設備可治療影響大腦、脊髓和周邊神經系統的疾病，包括癲癇、腦性麻痹、發育遲緩和神經退化性疾病。其範圍涵蓋神經影像工具、腦電圖系統、神經調節設備和穿戴式監測解決方案。這些專為兒科患者量身定做的設備優先考慮安全性、舒適性和準確性，從而能夠及早發現、有效干預並改善兒童的長期神經系統健康狀況。

根據美國癌症協會 (2023) 的統計，估計每年在兒童和青少年中診斷出超過 4,000 例腦和脊髓腫瘤。

兒童神經系統疾病盛行率上升

醫院和診所正在擴展其診斷和治療能力，以應對複雜的兒科神經系統疾病。早發性疾病正在推動慢性器械的使用和多學科護理模式的發展。影像、監測和腦脊髓液管理方面的技術進步正在支持精準醫療。公共衛生措施和看護者意識的提升正在增強早期療育。這些動態使疾病的流行成為兒科神經系統器械市場的關鍵驅動力，並推動整體市場的成長。

先進設備和程序高成本

規模較小的醫院和資源匱乏的地區在實施和維護高階系統方面面臨挑戰。報銷差距和有限的保險覆蓋範圍阻礙了新興市場的普及。兒科客製化增加了設備開發的複雜性和成本。培訓要求和法規遵從性進一步增加了營運成本。儘管臨床需求不斷成長，但這些因素仍在限制市場擴張。

更重視早期診斷和早期療育

新生兒和兒科神經病學計畫的擴展使得更早發現結構和功能異常成為可能。影像學、基因檢測和數位監測的整合正在提高診斷的準確性。公共和私人部門對小兒科研究和醫療保健基礎設施的投資正在推動技術創新。宣傳宣傳活動和學校篩檢計畫的範圍正在擴大。這些發展為市場成長創造了有利條件，並加速了兒科神經病學設備的普及。

技術挑戰和設備可靠性問題

設備故障、感染風險和再次手術引發了臨床醫生和看護者的擔憂。製造商必須投資嚴格的測試、真實世界檢驗和上市後監測，以確保安全。全球市場的監管審查和責任風險正在加劇。兒科特定結果數據的有限性延緩了創新和核准進度。這些限制構成了策略風險，並限制了全面的市場推廣。

COVID-19的影響

新冠疫情擾亂了兒科神經病學設備市場，導致供應鏈暫時中斷、生產停頓以及擇期手術延遲。小兒科醫院和神經病學中心的患者數量下降，影響了設備利用率和採購。然而，對遠端神經病學、遠端監控和數位診斷的關注度增加部分抵消了市場放緩的影響。疫情後的復甦將由對微創、技術驅動的兒科神經病學解決方案以及腦脊髓液管理和神經監測領域創新技術的需求成長所推動。

預測期內，腦脊髓液（CSF）管理設備市場預計將成為最大的市場

預計腦脊髓液 (CSF) 管理設備領域將在預測期內佔據最大的市場佔有率，這得益於其在治療水腦症和顱內高壓方面的廣泛應用。分流系統、引流套件和監測工具已部署在兒童神經外科病房。原始設備製造商 (OEM) 正在最佳化設備設計，考慮耐用性、感染控制和特定年齡層的適用性。醫院、專科診所和居家醫療的需求仍然強勁。監管部門對兒科設備技術創新的支持正在推動其應用。該領域繼續在兒科神經系統設備市場佔據主導地位，推動整體市場成長。

預計神經科科診所部門在預測期內的複合年成長率最高

在預測期內，神經科診所領域預計將實現最高成長率，這得益於對專科門診兒科神經科護理的需求。診所正在擴展神經診斷、發育評估和基於設備的干涉等服務。與遠端醫療、電子病歷 (EMR) 系統和多學科團隊的整合正在增強醫療服務。公共和私人對兒科神經科基礎設施的投資正在加速診所的擴張。對便利、以家庭為中心的醫療服務的需求正在成長。該領域正在成為兒科神經設備部署的高成長前沿，加速市場擴張。

比最大的地區

在預測期內，北美預計將佔據最大的市場佔有率，這得益於其先進的醫療基礎設施、高度的疾病認知度以及強大的報銷生態系統。美國和加拿大在兒科神經病學研究、設備創新和臨床應用方面發揮主導作用。罕見疾病管理和神經發育護理領域的公共舉措正在增強需求。原始設備製造商和學術機構正在推動產品開發和監管核准。保險覆蓋和臨床試驗活動正在支持其廣泛應用。

複合年成長率最高的地區

在預測期內，亞太地區預計將呈現最高的複合年成長率，這得益於兒科人口的成長、醫療保健可及性的提高以及政府對兒科護理的投入。中國、印度、日本和韓國等國家正在擴大兒科神經病學計畫和設備採購。官民合作關係和行動醫療計劃正在改善醫療服務不足地區的診斷和治療。對經濟實惠的、特定年齡層設備的需求正在推動技術創新。區域製造商和全球公司正在合作，以在地化和擴展解決方案。

免費客製化服務

此報告的訂閱者可以選擇以下免費自訂選項之一：

  • 公司簡介
    • 全面分析其他市場參與者（最多 3 家公司）
    • 主要企業的SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家進行的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球兒科神經系統設備市場（按產品）

  • 神經刺激設備
    • 深部腦部刺激（DBS）
    • 經顱磁刺激（TMS）
    • 迷走神經刺激（VNS）
  • 神經外科設備
    • 手術導引系統
    • 神經科學用內視鏡
    • 立體定位手術系統
  • 介入性神經病學設備
    • 顱內支架
    • 神經血管導管
  • 腦脊髓液（CSF）管理設備
    • 分流
    • 排水系統
  • 其他

6. 全球兒科神經系統設備市場（依疾病狀況）

  • 癲癇
  • 腦性麻痹
  • 水腦症
  • 腦腫瘤
  • 神經遺傳性疾病
  • 創傷性腦損傷（TBI）

7. 全球兒科神經系統設備市場（按服務和治療）

  • 診斷服務
  • 外科手術干預
  • 復健服務

8. 全球兒科神經系統設備市場（依最終用戶）

  • 醫院
  • 神經科診所
  • 復健中心
  • 研究所
  • 其他

9. 全球兒科神經系統設備市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第10章：重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司概況

  • Medtronic plc
  • Boston Scientific Corporation
  • Philips Healthcare
  • Siemens Healthineers
  • GE Healthcare
  • Natus Medical Incorporated
  • Stryker Corporation
  • B. Braun Melsungen AG
  • Integra LifeSciences Corporation
  • Elana, Inc.
  • Ethicon Inc.
  • Inova Health System
  • The Nemours Foundation
  • BrainSpec Inc.
  • St. Jude Medical, Inc.
Product Code: SMRC31195

According to Stratistics MRC, the Global Pediatric Neurology Device Market is accounted for $4.3 billion in 2025 and is expected to reach $7.9 billion by 2032 growing at a CAGR of 8.9% during the forecast period. A Pediatric Neurology Device is a medical instrument or technology specifically designed to diagnose, monitor, or treat neurological disorders in children, from newborns to adolescents. These devices address conditions affecting the brain, spinal cord, and peripheral nervous system, including epilepsy, cerebral palsy, developmental delays, and neurodegenerative disorders. They range from neuroimaging tools and electroencephalography (EEG) systems to neuromodulation devices and wearable monitoring solutions. Tailored to pediatric patients, these devices prioritize safety, comfort, and accuracy, enabling early detection, effective intervention, and improved long-term neurological health outcomes in children.

According to the American Cancer Society (2023), it was estimated that more than 4,000 brain and spinal cord tumors were diagnosed each year in children and teens.

Market Dynamics:

Driver:

Rising prevalence of paediatric neurological disorders

Hospitals and clinics are expanding diagnostic and therapeutic capabilities to manage complex neurological conditions in children. Early-onset disorders are prompting long-term device use and multidisciplinary care models. Technological advancements in imaging, monitoring, and CSF management are supporting precision treatment. Public health initiatives and caregiver awareness are reinforcing early intervention. These dynamics are positioning disease prevalence as a key driver of the pediatric neurology device market, thereby boosting overall market growth.

Restraint:

High costs of advanced devices and procedures

Smaller hospitals and low-resource regions face challenges in acquiring and maintaining high-end systems. Reimbursement gaps and limited insurance coverage are slowing adoption in emerging markets. Customization for pediatric use adds complexity and cost to device development. Training requirements and regulatory compliance further increase operational overhead. These factors are tempering market expansion despite rising clinical demand.

Opportunity:

Growing emphasis on early diagnosis and intervention

Expansion of neonatal and pediatric neurology programs is enabling earlier detection of structural and functional abnormalities. Integration with imaging, genetic testing, and digital monitoring is enhancing diagnostic accuracy. Public and private investments in pediatric research and care infrastructure are accelerating innovation. Awareness campaigns and school-based screening initiatives are expanding reach. These developments are creating favorable conditions for market growth, thereby accelerating adoption of pediatric neurology devices.

Threat:

Technical challenges and device reliability issues

Device malfunction, infection risk, and revision surgeries are raising concerns among clinicians and caregivers. Manufacturers must invest in rigorous testing, real-world validation, and post-market surveillance to ensure safety. Regulatory scrutiny and liability risks are increasing across global markets. Limited data on pediatric-specific outcomes is slowing innovation and approval timelines. These limitations are introducing strategic risk and constraining full-scale market deployment.

Covid-19 Impact:

The Covid-19 pandemic disrupted the Paediatric Neurology Device market, causing temporary supply chain interruptions, production halts, and delays in elective procedures. Paediatric hospitals and neurology centres experienced reduced patient volumes, impacting device utilization and procurement. However, the increased focus on tele-neurology, remote monitoring, and digital diagnostics partially offset the slowdown. Post-pandemic recovery is driven by growing demand for resilient, minimally invasive, and technology-enabled paediatric neurology solutions, along with innovations in CSF management and neuro-monitoring across care settings.

The cerebrospinal fluid (CSF) management devices segment is expected to be the largest during the forecast period

The cerebrospinal fluid (CSF) management devices segment is expected to account for the largest market share during the forecast period owing to its widespread use in treating hydrocephalus and intracranial pressure disorders. Shunt systems, drainage kits, and monitoring tools are being deployed across paediatric neurosurgical units. OEMs are optimizing device design for durability, infection control, and age-specific compatibility. Demand remains strong across hospitals, specialty clinics, and home care settings. Regulatory support for paediatric device innovation is reinforcing adoption. This segment continues to anchor the paediatric neurology device market, thereby boosting overall market growth.

The neurology clinics segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the neurology clinics segment is predicted to witness the highest growth rate driven by demand for specialized, outpatient-based paediatric neurological care. Clinics are expanding services in neurodiagnostics, developmental assessments, and device-based interventions. Integration with telehealth, EMR systems, and multidisciplinary teams is enhancing care delivery. Public and private investments in paediatric neurology infrastructure are accelerating clinic expansion. Demand for accessible, family-centered care is reinforcing momentum. This segment is emerging as a high-growth frontier for paediatric neurology device deployment, thereby accelerating market expansion.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share due to its advanced healthcare infrastructure, high disease awareness, and strong reimbursement ecosystem. The U.S. and Canada are leading in paediatric neurology research, device innovation, and clinical adoption. Public initiatives in rare disease management and neurodevelopmental care are reinforcing demand. OEMs and academic institutions are driving product development and regulatory approvals. Insurance coverage and clinical trial activity are supporting widespread deployment.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR driven by rising paediatric population, expanding healthcare access, and government investment in child health. Countries like China, India, Japan, and South Korea are scaling paediatric neurology programs and device procurement. Public-private partnerships and mobile health initiatives are improving diagnosis and treatment in underserved areas. Demand for affordable, age-specific devices is reinforcing innovation. Regional manufacturers and global players are collaborating to localize and scale solutions.

Key players in the market

Some of the key players in Paediatric Neurology Device Market include Medtronic plc, Boston Scientific Corporation, Philips Healthcare, Siemens Healthineers, GE Healthcare, Natus Medical Incorporated, Stryker Corporation, B. Braun Melsungen AG, Integra LifeSciences Corporation, Elana, Inc., Ethicon Inc., Inova Health System, The Nemours Foundation, BrainSpec Inc. and St. Jude Medical, Inc.

Key Developments:

In June 2025, Philips launched IntelliSpace Cognition, a cloud-based platform for automated neuropsychological testing, now being adapted for pediatric use. The tool enables longitudinal tracking of cognitive development and supports early intervention in neurodevelopmental disorders.

In January 2025, Boston Scientific launched Cartesia(TM) directional leads and the Lumina 3D programming algorithm for DBS, now being adapted for paediatric use. These innovations improve precision and reduce side effects in children with epilepsy and dystonia.

Products Covered:

  • Neurostimulation Devices
  • Neurosurgery Devices
  • Interventional Neurology Devices
  • Cerebrospinal Fluid (CSF) Management Devices
  • Other Products

Conditions Covered:

  • Epilepsy
  • Cerebral Palsy
  • Hydrocephalus
  • Brain Tumors
  • Neurogenetic Disorders
  • Traumatic Brain Injury (TBI)

Service & Treatments Covered:

  • Diagnostic Services
  • Surgical Interventions
  • Rehabilitation Services

End Users Covered:

  • Hospitals
  • Neurology Clinics
  • Rehabilitation Centers
  • Research Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Paediatric Neurology Device Market, By Product

  • 5.1 Introduction
  • 5.2 Neurostimulation Devices
    • 5.2.1 Deep Brain Stimulation (DBS)
    • 5.2.2 Transcranial Magnetic Stimulation (TMS)
    • 5.2.3 Vagus Nerve Stimulation (VNS)
  • 5.3 Neurosurgery Devices
    • 5.3.1 Surgical Navigation Systems
    • 5.3.2 Neuroendoscopy
    • 5.3.3 Stereotactic Surgery Systems
  • 5.4 Interventional Neurology Devices
    • 5.4.1 Intracranial Stents
    • 5.4.2 Neurovascular Catheters
  • 5.5 Cerebrospinal Fluid (CSF) Management Devices
    • 5.5.1 Shunts
    • 5.5.2 Drainage Systems
  • 5.6 Other Products

6 Global Paediatric Neurology Device Market, By Condition

  • 6.1 Introduction
  • 6.2 Epilepsy
  • 6.3 Cerebral Palsy
  • 6.4 Hydrocephalus
  • 6.5 Brain Tumors
  • 6.6 Neurogenetic Disorders
  • 6.7 Traumatic Brain Injury (TBI)

7 Global Paediatric Neurology Device Market, By Service & Treatment

  • 7.1 Introduction
  • 7.2 Diagnostic Services
  • 7.3 Surgical Interventions
  • 7.4 Rehabilitation Services

8 Global Paediatric Neurology Device Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Neurology Clinics
  • 8.4 Rehabilitation Centers
  • 8.5 Research Institutes
  • 8.6 Other End Users

9 Global Paediatric Neurology Device Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Medtronic plc
  • 11.2 Boston Scientific Corporation
  • 11.3 Philips Healthcare
  • 11.4 Siemens Healthineers
  • 11.5 GE Healthcare
  • 11.6 Natus Medical Incorporated
  • 11.7 Stryker Corporation
  • 11.8 B. Braun Melsungen AG
  • 11.9 Integra LifeSciences Corporation
  • 11.10 Elana, Inc.
  • 11.11 Ethicon Inc.
  • 11.12 Inova Health System
  • 11.13 The Nemours Foundation
  • 11.14 BrainSpec Inc.
  • 11.15 St. Jude Medical, Inc.

List of Tables

  • Table 1 Global Paediatric Neurology Device Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Paediatric Neurology Device Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Paediatric Neurology Device Market Outlook, By Neurostimulation Devices (2024-2032) ($MN)
  • Table 4 Global Paediatric Neurology Device Market Outlook, By Deep Brain Stimulation (DBS) (2024-2032) ($MN)
  • Table 5 Global Paediatric Neurology Device Market Outlook, By Transcranial Magnetic Stimulation (TMS) (2024-2032) ($MN)
  • Table 6 Global Paediatric Neurology Device Market Outlook, By Vagus Nerve Stimulation (VNS) (2024-2032) ($MN)
  • Table 7 Global Paediatric Neurology Device Market Outlook, By Neurosurgery Devices (2024-2032) ($MN)
  • Table 8 Global Paediatric Neurology Device Market Outlook, By Surgical Navigation Systems (2024-2032) ($MN)
  • Table 9 Global Paediatric Neurology Device Market Outlook, By Neuroendoscopy (2024-2032) ($MN)
  • Table 10 Global Paediatric Neurology Device Market Outlook, By Stereotactic Surgery Systems (2024-2032) ($MN)
  • Table 11 Global Paediatric Neurology Device Market Outlook, By Interventional Neurology Devices (2024-2032) ($MN)
  • Table 12 Global Paediatric Neurology Device Market Outlook, By Intracranial Stents (2024-2032) ($MN)
  • Table 13 Global Paediatric Neurology Device Market Outlook, By Neurovascular Catheters (2024-2032) ($MN)
  • Table 14 Global Paediatric Neurology Device Market Outlook, By Cerebrospinal Fluid (CSF) Management Devices (2024-2032) ($MN)
  • Table 15 Global Paediatric Neurology Device Market Outlook, By Shunts (2024-2032) ($MN)
  • Table 16 Global Paediatric Neurology Device Market Outlook, By Drainage Systems (2024-2032) ($MN)
  • Table 17 Global Paediatric Neurology Device Market Outlook, By Other Products (2024-2032) ($MN)
  • Table 18 Global Paediatric Neurology Device Market Outlook, By Condition (2024-2032) ($MN)
  • Table 19 Global Paediatric Neurology Device Market Outlook, By Epilepsy (2024-2032) ($MN)
  • Table 20 Global Paediatric Neurology Device Market Outlook, By Cerebral Palsy (2024-2032) ($MN)
  • Table 21 Global Paediatric Neurology Device Market Outlook, By Hydrocephalus (2024-2032) ($MN)
  • Table 22 Global Paediatric Neurology Device Market Outlook, By Brain Tumors (2024-2032) ($MN)
  • Table 23 Global Paediatric Neurology Device Market Outlook, By Neurogenetic Disorders (2024-2032) ($MN)
  • Table 24 Global Paediatric Neurology Device Market Outlook, By Traumatic Brain Injury (TBI) (2024-2032) ($MN)
  • Table 25 Global Paediatric Neurology Device Market Outlook, By Service & Treatment (2024-2032) ($MN)
  • Table 26 Global Paediatric Neurology Device Market Outlook, By Diagnostic Services (2024-2032) ($MN)
  • Table 27 Global Paediatric Neurology Device Market Outlook, By Surgical Interventions (2024-2032) ($MN)
  • Table 28 Global Paediatric Neurology Device Market Outlook, By Rehabilitation Services (2024-2032) ($MN)
  • Table 29 Global Paediatric Neurology Device Market Outlook, By End User (2024-2032) ($MN)
  • Table 30 Global Paediatric Neurology Device Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 31 Global Paediatric Neurology Device Market Outlook, By Neurology Clinics (2024-2032) ($MN)
  • Table 32 Global Paediatric Neurology Device Market Outlook, By Rehabilitation Centers (2024-2032) ($MN)
  • Table 33 Global Paediatric Neurology Device Market Outlook, By Research Institutes (2024-2032) ($MN)
  • Table 34 Global Paediatric Neurology Device Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.